Arlington to develop one of London’s first dedicated life science developments

Arlington has received full planning consent for a building that is set to become one of London’s first fully lab-enabled buildings to be delivered by a commercial property investor.

Known as Refinery, the building will be developed alongside Waterfront at Manbré Wharf which enjoys a Thames-side location in Hammersmith, west London. It will be launched to the market later this year and will take 2 years to complete.

The 123,000 sq ft development will be capable of accommodating Biosecurity Level 2 laboratory space alongside conventional offices. Unlike other lab enabled development, 100% of each floor of Refinery will be capable of being fitted out for laboratory use, giving life science and innovation companies total flexibility. Alongside conventional space Arlington will be delivering serviced and managed Laboratory space, with 20% of the building dedicated to collaboration and amenity space, including an event studio, restaurant, club room and business lounge.

Daniel Pagella, Commercial Director at Arlington commented: “Manbré Wharf is a genuinely rare proposition for London. Being alongside the Thames, a stone’s throw from the hustle and bustle of central Hammersmith gives us an exciting canvas to work with. It has all the benefits of quick and easy access to London’s established innovation clusters, whilst offering an unmatched environment for organisations to thrive.

Refinery will be transformational for Manbré Wharf, adding a new Thames side park and plaza with a large proportion of the building dedicated to collaboration and amenity space. Our already thriving community will have some fantastic spaces to enjoy, helping us to attract and retain the brightest and best from the science and innovation community. We can’t wait to get people to site – as soon as it is safe to do so – and share our exciting plans in more detail.”

BNP Paribas Real Estate, JLL and Hanover Green advise Arlington.